Parkinsonism following neuroleptic withdrawal.
Nelli
A C
AC
Yarden
P E
PE
Guazzelli
M
M
Feinberg
I
I
D014150:Antipsychotic Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
D014150:Antipsychotic Agents